Transplant Immunopathology Flashcards

1
Q

Class 1 general

A

A,B,C nucleated cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Class 2 general

A

DR, DP, DQ APCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T vs B HLA markers

A
T - only class 1 
B - both
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inheritance of HLA antigens

A

25% chance that a brother or sister has a perfect match

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Low res HLA typing

A

Used for solid organ

Serological equivalent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

High res HLA typing

A

Allele level

Needed for stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Serological typing def

A

What is expressed on the actual cell surface is tested

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HLA antibody formation

A

Pregnancy - more pregnancy = better chance
Blood transfusions - use LRBCs in order to decrease risk
Prvious transplant - 90% within two weeks of allograft failure (more likely for HLA-DP antibodies)…cut off immunosuppression then better chance of prudcing ABS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HLA antibody screen process

A

Patient serum tested against a bunch of HLA antigens coupled to beads…specificities determined and listed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cPRA

A

Panel reactive antibodies….greater value means less probanbility of successful match

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

COld ischemic time

A

Longer that organ goes without oxygen and blood flow, greater chance it won;t work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MFI

A

Mean fluorescnece intensity…higher value means more antibodies and more concern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Virtual Crossmatch

A

Compare on paper

Look at donor HLAs and antibodies in recipient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Corssmatch

A

Detects preformed donor specific HLA antibodies in recipient
Utilize donor lymphocytes and recipient serum
Minimizes risk of hyperacute rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AHG-CDC crossmatch

A

Take lymphos from donor and separate into B and T…add patient serum and enhancing agent…use complement…if cell is dyed then determines if cell isdamaged…if damaged then incompatible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Flow cytometry crossmatch

A

Take lymphos from donor…add antibodies (1 to T and 1 to B)…add patient serum…add flueorescent anti0IgG antibody that sticks to antibodies and can see if shift vs. negative control

17
Q

Problem with crossmatch

A

Takes a few hours…okay for kidneys but not ideal for heart transplant

18
Q

Direct pathway T cell activation

A

Donor APCs will find way into recipient will find way into circulation…stimulates recipient helper T cells to amount response

19
Q

Indirect pathway T cell activation

A

INjured tissue cells are processed by recipient APCS and then presented to helper T cells

20
Q

Immunosuppressive agents

A

Cyclosporine A or tacrolimus (calcineurin inhibitor) used with mycophenolate and steroids

Predipose to infections and neoplasms

21
Q

Infections most common

A

In first 6 months post transplant

22
Q

Neoplasms

A

Skin (Basal cell carcinoma or squamous cell carcinoma)

Viral (cervical squamous cell carcinoma from HPV, Post-transplant lymphproliferative disoder from EBV, Kaposi’s sarcoma from HHV 8)

23
Q

Types of rejection

A

Hyperacute - AB mediation…secs to min
Acute - Cell or AB mediated…weeks to months or anytime with nonadherence
Chronic - multifactorail…months to years
Graft vs. host dz - cell mediated in stem cell trasnplant s

24
Q

Hyperacute rejection xenotransplantation

A

We have naturally occurring antiboides to animal HLAs so rapidly attack

25
Hyperacute rejection
to HLA, ABO, xeno Necrosis, vascular injury and thrombosis, interstital neutrophils
26
Acute rejection
Immune cells encounter molecules like seelectiins that slow them down and then find target...majority will be cytotoxic T cells
27
Acute rejection (AB)
Individual develops antibodies Peritubular capillaritis in the kidney C4d positivity by immunohistochemical stain or immunofluorescne
28
DSA
Donor specific antibody screen Can determien where there were mismatches
29
Chronic rejection in kidiney leads to
Increased basmenet membrane Peritubular capillary layering and glomerulitis
30
Chronic rejection in heart
Cardiac allograft vasculopathy | Narrowed lumens of coronary arteries (circumferential vs eccentric of atherosclerosis),...must retransplant
31
Chronic rehjection in lung
Obliterative bronchiolitis Bronchioles narrow and must retrnaplant
32
Liver chronic rejection
Bile duct loss (mostly in portal areas) and obliterative arteriopathy
33
Chronic rejection in kidney
Don't need to retransplant as urgently because can go back on dialysis
34
Autologous stem cell transplantation
Use own stem cells to transplant...not subject ot GVHD
35
Allogenic T cell depletion of donor
May reduce risk of GVHD Increase risk of filaure to engraft (because T cells must find their home) Increase risk of malginant tumor relapse because of leukemia vs T cell effect
36
GVHD pathophysiology
Treat patient with conditioning...causes tissue injury...causes activation of APCs...donor T cells and host APCs lead to immune reaciton...a bunch of cytotoxic T cells ofdonor origin that circulate to tissues and cause damaage
37
Acute GVHD
Less than 100 post transplant | Skin, GI, and liver
38
Chronic GVHD
More than `00 days | Give immunosuppressant